Prevention of moderate and severe ovarian hyperstimulation syndrome a guideline

被引:20
作者
机构
[1] Amer Soc Reprod Med, Practice Comm, Washington, DC USA
关键词
Controlled ovarian stimulation; assisted reproductive technology; gonadotropins; risk; clomiphene citrate; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; ENDOTHELIAL GROWTH-FACTOR; FINAL OOCYTE MATURATION; HIGH-RISK PATIENTS; INTRAVENOUS ALBUMIN; GNRH AGONIST; EMBRYO-TRANSFER; DOPAMINE AGONIST; TREATMENT CYCLES;
D O I
10.1016/j.fertnstert.2023.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. This systematic review aims to identify who is at high risk for developing ovarian hyperstimulation syndrome, along with evidence -based strategies to prevent it and replaces the document of the same name last published in 2016. (Fertil Sterile 2024;121:230-45. (c) 2023 by American Society for Reproductive Medicine.)
引用
收藏
页码:230 / 245
页数:16
相关论文
共 117 条
[11]   Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study [J].
Bellver, J ;
Muñoz, EA ;
Ballesteros, A ;
Soares, SR ;
Bosch, E ;
Simón, C ;
Pellicer, A ;
Remohí, J .
HUMAN REPRODUCTION, 2003, 18 (11) :2283-2288
[12]   The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial [J].
Ben-Chetrit, A ;
Eldar-Geva, T ;
Gal, M ;
Huerta, M ;
Mimon, T ;
Algur, N ;
Diamant, YZ ;
Margalioth, EJ .
HUMAN REPRODUCTION, 2001, 16 (09) :1880-1884
[13]   OVARIAN HYPERSTIMULATION SYNDROME - A REVIEW OF PATHOPHYSIOLOGY [J].
BERGH, PA ;
NAVOT, D .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1992, 9 (05) :429-438
[14]   Risk of ovarian torsion is reduced in GnRH agonist triggered freeze-all cycles: a retrospective cohort study [J].
Berkkanoglu, Murat ;
Coetzee, Kevin ;
Bulut, Hasan ;
Ozgur, Kemal .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 39 (02) :212-217
[15]   Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles [J].
Bodri, Daniel ;
Jose Guillen, Juan ;
Polo, Ana ;
Trullenque, Marta ;
Esteve, Carolina ;
Coll, Oriol .
REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 17 (02) :237-243
[16]   Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study [J].
Carizza, Carlos ;
Abdelmassih, Vicente ;
Abdelmassih, Soraya ;
Ravizzini, Pedro ;
Salgueiro, Lister ;
Salgueiro, Paulo Tudech ;
Jine, Lin Tao ;
Nagy, Peter ;
Abdelmassih, Roger .
REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 17 (06) :751-755
[17]   Comoarison of coastina and intravenous albumin in the prevention of ovarian hyperstimulation syndrome [J].
Chen, CD ;
Chao, KH ;
Yang, JH ;
Chen, SU ;
Ho, HN ;
Yang, YS .
FERTILITY AND STERILITY, 2003, 80 (01) :86-90
[18]   A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome [J].
Chen, Yilu ;
Yang, Tanchu ;
Hao, Cuifang ;
Zhao, Junzhao .
MEDICAL SCIENCE MONITOR, 2018, 24 :4248-4253
[19]   Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study [J].
Chen, Yuan-hui ;
Xu, Xiao-hang ;
Wang, Qian ;
Zhang, Shao-di ;
Jiang, Li-le ;
Zhang, Cui-lian ;
Ge, Zhao-jia .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2015, 32 (10) :1459-1467
[20]   GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome [J].
Christopoulos, Georgios ;
Vlismas, Antonios ;
Carby, Anna ;
Lavery, Stuart ;
Trew, Geoffrey .
HUMAN FERTILITY, 2016, 19 (03) :199-206